Castle Biosciences
CSTL
CSTL
197 hedge funds and large institutions have $706M invested in Castle Biosciences in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 67 increasing their positions, 65 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 65
4% less capital invested
Capital invested by funds: $737M → $706M (-$30.5M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
197
Holding in Top 10
2
Calls
$3.7M
Puts
$996K
Top Buyers
| 1 | +$20.2M | |
| 2 | +$19.2M | |
| 3 | +$10.9M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$6.71M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$6.64M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$12.8M | |
| 3 | -$10.9M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$9.64M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$9.47M |